Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.
about
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisCrucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4)Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.Combination of lactate calcium salt with 5-indanesulfonamide and α-cyano-4-hydroxycinnamic acid to enhance the antitumor effect on HCT116 cells via intracellular acidificationMonocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patientsMCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer TherapiesThe Role of pH Regulation in Cancer Progression.High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma.Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer.An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implicationsStatin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
P2860
Q26771312-B15B449E-D0F0-4FF1-86BB-CD98F2992FFEQ28535008-69CA0154-DC98-42CD-9562-5C637DF37702Q36086546-A2BF4567-729D-43B4-B460-F19AF1D9CD00Q36640636-0DAA585F-CB35-4380-ACEC-B4815BE39E87Q37534686-8BC5D396-BB6C-4C1B-AE1D-9A06E4F97704Q37536613-D016B3B2-F2EC-474B-A84A-7BD34173501AQ38731939-2FF24B7A-9263-4B02-A67D-63F1A57ECB9FQ38936259-65DA9FC3-A67C-43B3-959B-253363DD9153Q45750314-30B94E42-4BC3-4842-A914-CEAC307CF5DCQ46315704-0877B78A-72B6-475B-8446-C27DE62D660EQ47100203-0EDFB747-AF4F-458A-9806-418ED26879A6Q58790007-B14A841E-D019-459C-843B-50D07CC54C83Q59126976-1E4DD3EE-B5C6-40A0-B3B6-1B1C97B2BAD4
P2860
Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prognostic significance of mon ...... tients with colorectal cancer.
@ast
Prognostic significance of mon ...... tients with colorectal cancer.
@en
type
label
Prognostic significance of mon ...... tients with colorectal cancer.
@ast
Prognostic significance of mon ...... tients with colorectal cancer.
@en
prefLabel
Prognostic significance of mon ...... tients with colorectal cancer.
@ast
Prognostic significance of mon ...... tients with colorectal cancer.
@en
P2093
P2860
P356
P1476
Prognostic significance of mon ...... tients with colorectal cancer.
@en
P2093
Hiroto Izumi
Kimitoshi Kohno
Koji Yamaguchi
Noritaka Minagawa
Takayuki Torigoe
Yoshifumi Nakayama
Yuzuru Inoue
P2860
P356
10.3892/ETM.2011.361
P577
2011-10-07T00:00:00Z